| Literature DB >> 35208757 |
Júllia A S Nascimento1, Fernanda F Santos2, José F Santos-Neto1, Liana O Trovão1, Tiago B Valiatti2, Isabel C Pinaffi3, Mônica A M Vieira1, Rosa M Silva4, Ivan N Falsetti3, Ana C M Santos1, Tânia A T Gomes1.
Abstract
Urinary tract infections (UTI) affect community and healthcare patients worldwide and may have different clinical outcomes. We assessed the phylogenetic origin, the presence of 43 virulence factors (VFs) of diarrheagenic and extraintestinal pathogenic Escherichia coli, and the occurrence of hybrid strains among E. coli isolates from 172 outpatients with different types of UTI. Isolates from phylogroup B2 (46%) prevailed, followed by phylogroups A (15.7%) and B1 (12.2%), with similar phylogenetic distribution in symptomatic and asymptomatic patients. The most frequent VFs according to their functional category were fimA (94.8%), ompA (83.1%), ompT (63.3%), chuA (57.6%), and vat (22%). Using published molecular criteria, 34.3% and 18.0% of the isolates showed intrinsic virulence and uropathogenic potential, respectively. Two strains carried the eae and escV genes and one the aggR gene, which classified them as hybrid strains. These hybrid strains interacted with renal and bladder cells, reinforcing their uropathogenic potential. The frequency of UPEC strains bearing a more pathogenic potential in the outpatients studied was smaller than reported in other regions. Our data contribute to deepening current knowledge about the mechanisms involved in UTI pathogenesis, especially among hybrid UPEC strains, as these could colonize the host's intestine, leading to intestinal infections followed by UTI.Entities:
Keywords: DEC; Escherichia coli; ExPEC; UPEC; epidemiology; hybrid E. coli strains; outpatients; phylogeny; urinary tract infection; virulence factors
Year: 2022 PMID: 35208757 PMCID: PMC8874565 DOI: 10.3390/microorganisms10020302
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Molecular markers used to identify the Escherichia coli pathotypes.
| Pathotype | Molecular Markers |
|---|---|
| EAEC |
|
| ETEC | |
| EIEC |
|
| typical EPEC | |
| atypical EPEC | |
| STEC | |
| EHEC | |
| ExPEC+ (intrinsic virulence) a | |
| UPEC+ (uropathogenic potential) a |
a The Escherichia coli strains isolated from UTI were considered to belong to the ExPEC/UPEC pathotype. The usage of the molecular markers intends to identify strains harboring a more specific pathogenic profile as previously described [26,34,35].
Frequency of DEC and ExPEC virulence factors (VFs) and phylogroups of urinary tract infection strains (n (%)).
| All Isolates | ExPEC+ a | UPEC+ b | Non-UPEC+/ExPEC+ | ||
|---|---|---|---|---|---|
| Traits | VFs | ||||
|
|
| 163 (94.8) | 57 (96.6) | 29 (93.5) | 95 (94) |
|
| 143 (83.1) | 46 (77.9) | 27 (87.1) | 86 (85.1) | |
|
| 72 (41.8) | 36 (61) *** | 31 (100) *** | 24 (23.7) | |
|
| 72 (41.8) | 30 (50.8) | 13 (41.9) | 37 (36.6) | |
|
| 61 (35.4) | 32 (54.2) ** | 17 (54.8) * | 26 (25.7) | |
|
| 48 (27.9) | 40 (67.8) *** | 14 (45.2) *** | 7 (6.9) | |
|
| 37 (21.5) | 23 (38.9) *** | 12 (38.7) ** | 10 (9.9) | |
|
| 28 (16.2) | 23 (38.9) *** | 8 (25.8) * | 5 (4.9) | |
|
| 19 (11) | 7 (11.8) | 4 (12.9) | 10 (9.9) | |
|
| 14 (8.1) | 2 (3.3) | 2 (6.4) | 10 (9.9) | |
|
| 2 (1.1) | 2 (3.3) | 0 (0) | 0 (0) | |
|
| 2 (1.1) | 0 (0) | 1 (3.2) | 1 (0.9) | |
|
| 1 (0.5) | 0 (0) | 1 (3.2) | 0 (0) | |
|
|
| 109 (63.3) | 52 (88.1) *** | 28 (90.3) *** | 46 (45.5) |
| 77 (44.7) | 51 (86.4) *** | 24 (77.4) *** | 20 (19.8) | ||
|
| 72 (41.9) | 34 (57.6) * | 20 (64.5) * | 32 (31.6) | |
| 2 (1.1) | 1 (1.6) | 2 (6.4) * | 0 (0) | ||
|
| 16 (9.3) | 8 (13.6) | 5 (16.1) | 7 (6.9) | |
|
|
| 99 (57.6) | 53 (89.8) *** | 31 (100) *** | 34 (33.6) |
|
| 89 (51.7) | 37 (62.7) * | 31 (100) *** | 40 (39.6) | |
|
| 88 (51.1) | 35 (59.3) | 20 (64.5) | 46 (45.5) | |
|
| 57 (33.1) | 33 (55.9) *** | 21 (67.7) *** | 18 (17.8) | |
|
| 41 (23.8) | 29 (49.1) *** | 9 (29) * | 11 (10.9) | |
|
| 15 (8.7) | 8 (13.6) * | 4 (12.9) | 4 (3.9) | |
|
|
| 38 (22) | 19 (32.2) *** | 31 (100) *** | 7 (6.9) |
|
| 22 (12.7) | 12 (20.3) * | 4 (12.9) | 8 (7.9) | |
|
| 18 (10.4) | 16 (27.1) *** | 5 (16.1) * | 2 (1.9) | |
|
| 17 (9.9) | 11 (18.6) * | 7 (22.6) ** | 3 (2.9) | |
|
| 9 (5.2) | 7 (11.8) * | 2 (6.4) | 1 (0.9) | |
|
| 6 (3.5) | 4 (6.7) | 4 (12.9) * | 1 (0.9) | |
|
|
| 1 (0.5) | 0 (0) | 0 (0) | 1 (0.9) |
|
|
| 2 (1.1) | 0 (0) | 1 (3.2) | 1 (0.9) |
|
| 59 (34.3) | N.A. | 19 (61.2) | N.A. | |
|
| 31 (18) | 19 (32.2) | N.A. | N.A. | |
|
| 3 (1.7) | 0 (0) | 1 (3.2) | 2 (1.9) | |
|
| |||||
|
| 27 (15.7) | 0 (0) (***) | 0 (0) (**) | 27 (26.7) | |
|
| 21 (12.2) | 2 (3.3) (*) | 0 (0) (*) | 19 (18.8) | |
|
| 79 (46) | 49 (83) *** | 30 (96.8) *** | 19 (18.8) | |
|
| 14 (8.1) | 4 (6.7) | 0 (0) | 10 (9.9) | |
|
| 4 (2.3) | 2 (3.3) | 0 (0) | 2 (1.9) | |
|
| 9 (5.2) | 2 (3.3) | 0 (0) | 7 (6.9) | |
|
| 5 (2.9) | 0 (0) | 0 (0) | 5 (4.9) | |
|
| 13 (7.5) | 0 (0) (*) | 1 (3.2) | 12 (11.8) |
a intrinsic virulence as determined by the presence of at least two among the genes papC, sfaDE, afaBCIII, iucD, and kpsMTII; b uropathogenic potential, as determined by the simultaneous presence of vat, chuA, fyuA, and yfcV; c strains that harbor a molecular marker related to DEC diagnosis (eae, escV, or aggR). N.A., not applicable. The differences in the frequency of VFs present in strains classified as ExPEC+ or UPEC+ were compared with those present in strains negative for both classifications, here named as non-ExPEC+/UPEC+ strains. Fisher exact test, * p ≤ 0.05; ** p < 0.001; *** p < 0.0001. The parenthesis means that the trait is negatively related with the ExPEC+/UPEC+ classification or statistically related to non-UPEC+/ExPEC+ group. All strains were negative to the following VFs: afaBCIII, afaE-VIII, bfpB, bmaE, cf29A, invE, cnf1, eltA, estA, stx1, and stx2.
Figure 1Adherence patterns of hybrid uropathogenic Escherichia coli (UPEC) strains to HeLa cells. Adherence patterns were evaluated in assays with incubation periods of 3 h or 6 h, at 37 °C, in the presence of 2% D-mannose, using a multiplicity of infection of 10. The preparations were stained with May-Grünwald/Giemsa and observed under an optical microscope (magnification ×1000). All hybrid UPEC strains were adherent. Strain LSC 052, showing the aggregative adherence (AA) pattern; strains LSC 073 and LSC 183, showing the localized adherence-like (LAL) pattern. E. coli strains used as controls: 042 (prototype enteroaggregative E. coli (EAEC) expressing AA; E2348/69 (prototype typical enteropathogenic E. coli (EPEC) expressing a localized adherence (LA) pattern); 4581-2 (atypical EPEC (aEPEC) showing the LAL pattern); CFT073 (prototype UPEC strain); HB101 (E. coli K-12-derived laboratory strain, non-adherent).
Figure 2Interaction of hybrid uropathogenic Escherichia coli (UPEC) strains with HEK 293T cells of renal origin. The ability of hybrid UPEC strains to interact with human kidney cells was evaluated in assays with an incubation period of 3 h, at 37 °C without D-mannose, using a multiplicity of infection of 10. The preparations were stained with May-Grünwald/Giemsa and observed under an optical microscope (magnification ×1000). All hybrid UPEC strains interacted with the kidney cells in different strengths. E. coli strains used as controls: 042 (prototype EAEC); E2348/69 (prototype typical EPEC); 4581-2 (atypical EPEC); CFT073 (prototype UPEC); HB101 strain (non-adherent E. coli K-12-derived laboratory strain).
Figure 3Interaction of hybrid uropathogenic Escherichia coli (UPEC) strains with T24 cells of bladder origin. The ability of hybrid UPEC strains to interact with human bladder cells was evaluated in assays with an incubation period of 3 h, at 37 °C, without D-mannose, using a multiplicity of infection of 10. The preparations were stained with May-Grünwald/Giemsa and observed under light microscopy (magnification ×1000). Hybrid UPEC/enteroaggregative E. coli (EAEC) strain (LSC 052) and hybrid UPEC/atypical enteropathogenic E. coli (aEPEC) strains (LSC 073 and LSC 183) interacted with bladder cells at different intensities. E. coli strains used as controls: 042 (prototype EAEC); E2348/69 (prototype typical EPEC); 4581-2 (atypical EPEC); CFT073 (prototype UPEC); HB101 strain (non-adherent E. coli K-12-derived laboratory strain).